The global medical grade sodium hyaluronate market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for medical grade sodium hyaluronate in various applications such as intrarticular injection, ophthalmic viscosurgical devices, antadhesive products, dermal filler and scaffold materials in tissue engineering.
The global medical grade sodium hyaluronate market is segmented on the basis of type into intrarticular injection, ophthalmic viscosurgical devices, antadhesive products and dermal filler. The intrarticular injection segment accounted for the largest share in 2018 owing to its wide range of applications such as joint replacement surgery and treatment for osteoarthritis among others. The ophthalmic viscosurgical devices segment is expected to witness significant growth during the forecast period owing to its application in cataract surgery among others.
On the basis of application type, woman accounted for a major share in 2018 due to their high demand for cosmetic procedures such as lip augmentation and breast augmentation among others which are carried out by using dermal fillers made from medical grade sodium hyaluronate. On the other hand man accounted for a major share due to their high demand for orthopedic surgeries which are carried out by using joint replacements made from medical grade sodium hyaluronate.
Some Of The Growth Factors Of This Market:
- The increasing number of aging population is also expected to fuel the growth of this market in the coming years due to increased incidence of joint pain and other related conditions among elderly people.
- Increasing awareness about benefits offered by medical grade sodium hyaluronate products is also anticipated to boost its demand in the near future as it offers relief from joint pain and other related conditions without any side effects associated with conventional treatments such as surgery or drugs that are often associated with adverse effects like nausea, vomiting, diarrhea, etc, which can be very debilitating for patients who are already suffering from chronic diseases like arthritis or osteoarthritis.
Industry Growth Insights published a new data on “Medical Grade Sodium Hyaluronate Market”. The research report is titled “Medical Grade Sodium Hyaluronate Market research by Types (Intra-articular Injection, Ophthalmic Viscosurgical Devices, Anti-adhesive Products, Dermal Filler, Scaffold Materials in Tissue Engineering, Others), By Applications (Woman, Man), By Players/Companies LG Group, HUONS, Allergan, Haohai Biological Technology, Altergon Italia, Stanford Chemicals, Beauty Aesthetic Finland, SYMATESE, RiverPharma, ORTOBRAND INTERNATIONAL, Qufu Guanglong Biochemical Factory, Freshine Chem”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Grade Sodium Hyaluronate Market Research Report
By Type
Intra-articular Injection, Ophthalmic Viscosurgical Devices, Anti-adhesive Products, Dermal Filler, Scaffold Materials in Tissue Engineering, Others
By Application
Woman, Man
By Companies
LG Group, HUONS, Allergan, Haohai Biological Technology, Altergon Italia, Stanford Chemicals, Beauty Aesthetic Finland, SYMATESE, RiverPharma, ORTOBRAND INTERNATIONAL, Qufu Guanglong Biochemical Factory, Freshine Chem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Medical Grade Sodium Hyaluronate Market Report Segments:
The global Medical Grade Sodium Hyaluronate market is segmented on the basis of:
Types
Intra-articular Injection, Ophthalmic Viscosurgical Devices, Anti-adhesive Products, Dermal Filler, Scaffold Materials in Tissue Engineering, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Woman, Man
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LG Group
- HUONS
- Allergan
- Haohai Biological Technology
- Altergon Italia
- Stanford Chemicals
- Beauty Aesthetic Finland
- SYMATESE
- RiverPharma
- ORTOBRAND INTERNATIONAL
- Qufu Guanglong Biochemical Factory
- Freshine Chem
Highlights of The Medical Grade Sodium Hyaluronate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intra-articular Injection
- Ophthalmic Viscosurgical Devices
- Anti-adhesive Products
- Dermal Filler
- Scaffold Materials in Tissue Engineering
- Others
- By Application:
- Woman
- Man
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Grade Sodium Hyaluronate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical grade sodium hyaluronate is a type of hyaluronic acid that has been specifically purified and processed to increase its effectiveness as a moisturizer. It is often used in topical treatments for skin conditions, such as psoriasis or eczema, because it can help keep the skin hydrated and protected from dryness.
Some of the major players in the medical grade sodium hyaluronate market are LG Group, HUONS, Allergan, Haohai Biological Technology, Altergon Italia, Stanford Chemicals, Beauty Aesthetic Finland, SYMATESE, RiverPharma, ORTOBRAND INTERNATIONAL, Qufu Guanglong Biochemical Factory, Freshine Chem.
The medical grade sodium hyaluronate market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Grade Sodium Hyaluronate Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Grade Sodium Hyaluronate Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Grade Sodium Hyaluronate Market - Supply Chain
4.5. Global Medical Grade Sodium Hyaluronate Market Forecast
4.5.1. Medical Grade Sodium Hyaluronate Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Grade Sodium Hyaluronate Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Grade Sodium Hyaluronate Market Absolute $ Opportunity
5. Global Medical Grade Sodium Hyaluronate Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Type
5.3.1. Intra-articular Injection
5.3.2. Ophthalmic Viscosurgical Devices
5.3.3. Anti-adhesive Products
5.3.4. Dermal Filler
5.3.5. Scaffold Materials in Tissue Engineering
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Grade Sodium Hyaluronate Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Application
6.3.1. Woman
6.3.2. Man
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Grade Sodium Hyaluronate Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Grade Sodium Hyaluronate Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Grade Sodium Hyaluronate Demand Share Forecast, 2019-2026
9. North America Medical Grade Sodium Hyaluronate Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Application
9.4.1. Woman
9.4.2. Man
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Type
9.7.1. Intra-articular Injection
9.7.2. Ophthalmic Viscosurgical Devices
9.7.3. Anti-adhesive Products
9.7.4. Dermal Filler
9.7.5. Scaffold Materials in Tissue Engineering
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Grade Sodium Hyaluronate Demand Share Forecast, 2019-2026
10. Latin America Medical Grade Sodium Hyaluronate Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Application
10.4.1. Woman
10.4.2. Man
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Type
10.7.1. Intra-articular Injection
10.7.2. Ophthalmic Viscosurgical Devices
10.7.3. Anti-adhesive Products
10.7.4. Dermal Filler
10.7.5. Scaffold Materials in Tissue Engineering
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Grade Sodium Hyaluronate Demand Share Forecast, 2019-2026
11. Europe Medical Grade Sodium Hyaluronate Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Application
11.4.1. Woman
11.4.2. Man
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Type
11.7.1. Intra-articular Injection
11.7.2. Ophthalmic Viscosurgical Devices
11.7.3. Anti-adhesive Products
11.7.4.Dermal Filler
11.7.5. Scaffold Materials in Tissue Engineering
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Grade Sodium Hyaluronate Demand Share, 2019-2026
12. Asia Pacific Medical Grade Sodium Hyaluronate Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Application
12.4.1. Woman
12.4.2. Man
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Type
12.7.1. Intra-articular Injection
12.7.2. Ophthalmic Viscosurgical Devices
12.7.3. Anti-adhesive Products
12.7.4. Dermal Filler
12.7.5. Scaffold Materials in Tissue Engineering
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Grade Sodium Hyaluronate Demand Share, 2019-2026
13. Middle East & Africa Medical Grade Sodium Hyaluronate Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Application
13.4.1. Woman
13.4.2. Man
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Grade Sodium Hyaluronate Market Size and Volume Forecast by Type
13.7.1. Intra-articular Injection
13.7.2. Ophthalmic Viscosurgical Devices
13.7.3. Anti-adhesive Products
13.7.4. Dermal Filler
13.7.5. Scaffold Materials in Tissue Engineering
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Grade Sodium Hyaluronate Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Grade Sodium Hyaluronate Market: Market Share Analysis
14.2. Medical Grade Sodium Hyaluronate Distributors and Customers
14.3. Medical Grade Sodium Hyaluronate Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. LG Group
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. HUONS
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Allergan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Haohai Biological Technology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Altergon Italia
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Stanford Chemicals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Beauty Aesthetic Finland
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SYMATESE
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. RiverPharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. ORTOBRAND INTERNATIONAL
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Qufu Guanglong Biochemical Factory
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Freshine Chem
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
